Dutch researchers found patient-centered diabetes care was associated with an A1C decline of 0.83% at one year and an incremental cost-effectiveness ratio of $261 per quality-adjusted life year in patients whose baseline A1C was greater than 8.5%. However, such an approach to care did not provide similar benefits in patients with baseline A1C below 7%, researchers reported in Diabetes Care.
Study ties higher baseline A1C to better patient-centered care results
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||